ACLU "Ready to Take Action," Touts Win Against Clearview AI

By Isabella Cheng, Published May 10, 2022, 12:08pm EDT (Info+)

Not only has the ACLU scored a major victory against Clearview AI, the ACLU tells IPVM it is "ready to take action" against other companies that take Clearview's approach to offering a massive facial recognition database.

IPVM Image

In this report, IPVM examines what this means for businesses engaged in controversial facial recognition technology moving forward and the terms of the settlement, including comments from the ACLU.

ACLU: "***** ** **** ******" ******* ********* ******* ** *********

*** **********, ***** **** ********* ** from ******* ** ******* ******** ****** the ** *** ** *** ********** in ******** *** * *****, ** a ******* **** *** *** ****** recognition ********* **** ******* ** ** business ** *** **.

*** **** ** ******** **** ******** closely, ** **** ** ****, *** "stands ***** ** **** ******" ******* companies ********** ** ********* ********* **:

*** **** ** ******** *** **** recognition ******** *******. ** **** **** settlement **** ** * ****** ********* to *** ***** ******* *********** *********** Clearview’s ******** ******** *****, *** ** stand ***** ** **** ****** ** that’s *** *** ****.

**** ********* *** ***** **** * facial *********** ********, *** **** ********** creates * ******** ****** *** ***** companies **** **** ** ** ***** this ******. ***** **** *** *** the ****, ** ***** ********* **** also *** $***,*** ** *********' **** to *** **********, ** ** * much ****** **** *** ****** **** who ***** ** ****** * ******* product.

********* ******* ************

** ********* *** **** **** *******, the ******* ****** ******* ** ***** that ** ***** **** ********** *** company. ********* ***** **** ***** ******* in *** **** ** ******** ** dollars ** ** *** **** ***** to **** ******** ****, ********* ** IPVM's ************. ******* ***** ******* ****** $*,*** ** $*,************ ** *** ************ ** *** violation, *** *** ********** ** ******** is ********* ~** ******* ******.

** ** ***** **** ********* ******** this ********** *** * **** **** for *** *******. **** ** ** had ********* ** ***** *** **** and ****, *** ******* ***** *** be ********** ** **** ** ******* entities ******* ** ********, ** ** is ***. *******, *** **** ** continuing ** ***** **** **** *** the *********** ** ******* *** *******'* financial *********, ** ***** ****** ** violating ****.

Banned **** ******* ***** ****** **

********* ** ***** * "******* ****** and ********** ***" ***** ******* ********* the ******* **** "******** **** ** free ****** ** *** ********* ********" to ******* ******** ****** *** **, according *** **-**** *** *, **** *************** *** ********** ******* ********* **, the ****, *** * ***** ********-***** public ******** ******.

************, *** *** ********* ********* **** giving ****** **:

(*)any ******* ****** ** ******* ***********, except (a) as consistent with 740 ILCS 14/25 (and applicable law referred to therein) or (b) in compliance with the requirements of 740 ILCS 14/15; and (2) any ********** ********** ******** *** ** *** ****** ** ***** ******** ******** ** ****** ** * ***** ** ******* ********** ******, or local unit of government. [emphasis added]

*** **** *** ***** ****** ******** groups**** ********* ** ** *** ****, ******** **** "*********’* **** ************ activities ******* *** ******** ********* *********** Privacy *** (****), *** ********* ** unprecedented ****** ** *** ******** *** safety."

Biometric *********** ******* *** (****) ******* ********

******* **** **/*******/******* ***** *** ***** ** ********' Biometric *********** ******* *** (****). ** would ** ************ ********** *** ********* or *** ***** ******* **** ******* hundreds ** ******** ** ****** **** the ******** ** ***** ** *** disclosure *** ******* ************ ** ****.

*** **** **/** ** *** ***** of **** ***** ******** ******* ******** companies **** **** ********* *********** ** inform ******** **** ***** *********** ** being *********:

(*) ** ******* ****** *** *******, capture, ********, ******* ******* *****, ** otherwise ****** * ******'* ** * customer's ********* ********** ** ********* ***********,unless ** *****:

(*)informs *** ******* or the subject's legally authorized representative in writing that a biometric identifier or biometric information is being collected or stored; [emphasis added]

*******, *** ******* ******* ********** **** receive * ******* ******* **** *** subject:

(*) ******** * ******* ******* ******** by *** ******* ** *** ********* identifier ** ********* *********** ** *** subject's ******* ********** **************.

**** **** ********* ******* ******** **** profiting *** * ******'* ********* ***********. Private ******** **** **** ********* *********** also ****** *********** **** *********** ******* disclosure ** *** ******* **** *** owner ** **** ********* ***********.

***** ********* **'* ********** ****** ***** scraping, ** ***** ** ****** ********** for ********* ** ** ****** *** receive ******* **** ***** ****** ** its ******** ** *** ** *** above.

Government *** ***** *******, ****** ** ********

*******, ********** *** ** ********* **, outside ** ********, ** ***** *******. The ********** ******:

*** *** ********* ** *****, **** Private ****** ***in ** *** ****** *********’* ******* ** **** **** ******* ********** ******** (or State government agencies outside of Illinois) and contractors engaged in authorized support for and under contracts with such government agencies at all levels and locations. [emphasis added]

** ********, ***** *** ******* *** filed *** ***** **** ******, ********* is ****** **** ****** ****** ** all ********, ********* *** **********, *** the **** * *****:

********* ****** ** *** ***** **an ********** *** * ****** ** **** (*) ***** from the date of the entry of the Consent Order prohibiting Clearview from granting either paid or free access to Illinois *****, ******, *****, ** ***** ********** ******** *** *********** working for those agencies in Illinois, including ***** *** ***** ****** *********** *** ***** ***** *** ***** *** *********** ******** (the “Illinois State and Local Agencies”), to the Clearview App. [emphasis added]

School *** ****** ** ********, ******* *********

****** *** ** ********* **** ** banned ** ******** *** * *****, but *** ********** **** *** ****** school *** ******* ** *** *****,****** ***** *******, ****** ******** ** *** **** Speech, *******, *** ********** *******, **** IPVM. ******* *** *** ** *** attorneys ************ *** ********** ** *** lawsuit ******* *********:

IPVM Image***** *** **********, *********will ** ****** *** **** ***** **** ********* ****** ** *** **** *********** ******** ** *** ***** ** ***** ********** ******** ** ********, ********* ****** *******. Even after that five-year period is over, a separate ******* ********* *********** ***** ******** **** ******** ** ********* how ****** ******* *** *** **** recognition ********** ** ***** ********. *** settlement **** *** ****** *** ******** Clearview ***** **** ** ** **** public ******* ******* ** ********. [******** added]

Sales ** ***** *******

********* ** **** **** ** **** to ********* ************, ********* *****, *** to * ******** ** ****,*** *** **** ***** ********. *** ********** **** ****** ** 14/25(c):

******* ** **** *** ***** ** deemed ** ***** ** *** ****** to * ********* *********** ** ** affiliate ** * ********* *********** **** is ******* ** ***** * ** the ******* *****-*****-****** *** ** **** and *** ***** *********** **********.

***** *** ********* ************ ***** **** an ********* ** *** ********* **'* database *** ******** ********.

Facial ******* ** ** *******

********* ** **** ****** ** ****** all ****** ******* ** *** ******** previous ** **** **********:

********* ****** ** ****** *** ****** vectors ** *** ********* *** **** existed ****** ********* ****** ********* ** selling ****** ** *** ********* *** to ******* *********** *** ******** (*** “Old ****** *******”).

*******, ********* ** ** ***** ****** to **** ******* ** ********** **** 740 **** **/** *** **/**. ************, 14/25 ***** ********** ** **********-******* ********:

******* ** **** *** ***** ** construed ** ***** ** * **********, subcontractor, ** ***** ** * ***** agency ** ***** **** ** ********** when ******* *** **** ***** ****** or ***** **** ** **********.

Opt-Out ******* *** ******** *********

********* ** **** **** *** $**,*** to *********** ** ******** ****** "*** Google, ********," ***. ** ****** ******** residents **** **** *** ***-*** ** having ***** ******** ********* ** *********. Illinois ********* *** ****** * ********** of ********** ****** ****** ******, **** ********* **** *** **** photo ** ******* *** ***-*** *******:

********* **** ****use *** ********** ** ***** *** ****** ******* **** ******* *********** ** **** ******** ******** and to prevent ****** ********** ** *********** ********** **** ******** ********, to the best of Clearview’s ability. [emphasis added]

5-Year ******** ***** *********

**** **** *******, ********* **** "****** out" ********-***** *********** **** *** ********* database *** *** **** * *****:

********* ***** ******** *** **** (*) years **** *** **** ** *** entry ** *** ******* ***** *********’* filter ******* ** ********* ***, ** the **** ** *********’* *******, ********-***** photographs **** *** ********* ***.

********* **** ** **** ** **** what *********** *** "********-*****" **** *** photos' ******* *** ********, *** ********** says.

Impact ** *********'* ********

*********'* ******** **** ** ************* ******** now **** ** ** ******* ****** from ******* ****** ** *** ******** to ******* ******** ****** *** **. Further, ********* **** **** ** *** $250,000 ** *********' **** ** * term ** *** **********.

*******, ********* ** ***** **** ** sell ** ********** ******** ******* ** Illinois, *** *** ********** *** ** big ******** *** *** *******. ********* is **** **** ** **** ** financial ************, ********* *****. ********* ********* sales ** *******, ****** ***********, ***********, and ***** ******* ** ******** ***** leaves * *********** ******** *********** *** Clearview.

ACLU ***** ******* ** **** *** ****

****** *********** ** * ************* **********, and **** ******* **** *********** ** the ****** **** **** ******** *** general ***. ******, *** **** **** IPVM **** ** ** ********** ** work ** ************ ****** *********** ***********:

*** ******** ********* *********** ******* *** regulates ******* **** ** ********* ********** technologies. *** *********** *** ********, *** they ***’* ******* ***** ****** ** face *********** **********. ****’* *** *** ACLU *** ****** **** ***** ******** to ***** ***** *** ***** **** on ****** *** ** **** *********** technology ** ****** ** ************* ****** the *******.

Comments (4)

* **** ** ********* ** **** this ********* ** * ***** "****" for *********, ******* *** **** **** to **** **. ****** ** *** clarified **** **** *** **** ** do *** **** **** *** ********** from ***** *** **** ******* ***** up *** **** ********* ** *** former **** **** ** *** ******. Unless, ***** ** ******** ********, **** I ** ******* *********.

“**** ********** ** * **** *** for ********* **,” ******** ****** & Block ******* *** *******, ************ *** company, ** * ********* ******** *********** ******. “********* ** **** **** ** changes ** *** ******* ******** *****. It **** ******** ** ****** *** business ********* ** ********** **** ********** law. *** ** **** *** * small ****** ** ***** ** ***** advertising *** ****, *** **** ***** than ********* ********** ***** ****.”

Agree: 1
Disagree
Informative
Unhelpful
Funny

****** *** ********** ****** *** *** of ******** *** **** ***********. *** question ** ******* **** ** *** end ** ******* ******* ******* ********* in *** ** ** **** **** face ******* ***** *******.

Agree
Disagree
Informative
Unhelpful
Funny

***, ********* ********* ** *** **** 2 ****** ***:

IPVM Image

********* ******* ** ***** ** ** but *** **** ** ********* * commercial **** *** *** *********** ** the ***** ******* *** *** ******* limited ** ********** ***.

Agree
Disagree
Informative
Unhelpful
Funny

**** ************** *** ***** **** *** stay ****** *** *** ****** ******* Back.

*** ***** **** ***** ******* ***** when *****'* ***** ** ** ****. I ***** **'* ****** * *****.

Agree
Disagree
Informative
Unhelpful
Funny: 1
Login to read this IPVM report.
Why do I need to log in?
IPVM conducts reporting, tutorials and software funded by subscriber's payments enabling us to offer the most independent, accurate and in-depth information.
Loading Related Reports